Overjet raises $42.5 million

Boston-based Overjet closed a $42.5 million Series B financing led by General Catalyst and Insight Partners with participation from existing investors Crosslink Capital and the MIT-affiliated E14 Fund in an oversubscribed round. Following the $27 million Series A round announced, just four months ago, in August 2021, Overjet has raised nearly $80 million in total financing to date.

The company’s dental AI technology encodes dentist-level understanding of disease identification and progression, and, earlier this year it secured FDA clearance for its Dental Assist product.

“Overjet’s cutting-edge software has seen incredible demand from clinicians and insurers alike who see our dental AI as a transformational technology to advance patient oral healthcare. The new financing will accelerate our next chapter of growth to support our customers, grow the team, and invest in the next generation of technology to support patient care.” – Dr. Wardah Inam, PhD, CEO and co-founder of Overjet.

On the insurance side, Overjet counts 16 major carriers as customers for coverage of over 73 million Americans. Overjet’s Claim Intelligence Platform supports consistency in dental claims review and improved operating efficiency for insurers.

“When we first met Overjet, we were immediately impressed by Wardah Inam’s vision to build the intelligence layer for dentistry. The market traction the team has achieved in such a short time attests to the value of their software solutions. We are delighted to again lead their funding round as they partner with clinicians and insurers to transform patient dental health.” – Chris Bischoff, Managing Director of General Catalyst.